These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4949 related articles for article (PubMed ID: 4139279)

  • 1. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
    Bucana C; Hanna MG
    J Natl Cancer Inst; 1974 Nov; 53(5):1313-23. PubMed ID: 4139279
    [No Abstract]   [Full Text] [Related]  

  • 2. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
    Minden P; McClatchy JK; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 Nov; 53(5):1325-31. PubMed ID: 4139280
    [No Abstract]   [Full Text] [Related]  

  • 3. Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.
    Borsos T; Rapp HJ
    J Natl Cancer Inst; 1973 Sep; 51(3):1085-6. PubMed ID: 4355214
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple in vitro mechanisms of tumor cytotoxicity demonstrated in the line-1 guinea pig hepatoma model.
    Osteen RT; Piessens WF; David JR; Churchill WH
    J Natl Cancer Inst; 1975 Oct; 55(4):873-8. PubMed ID: 52720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 6. Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG).
    Minden P; Sharpton TR; McClatchy JK
    J Immunol; 1976 May; 116(5):1407-14. PubMed ID: 58033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic analysis between BCG and tumor cells by BCG-monoclonal antibodies.
    Sasaki J; Kitagawa M; Tamagake T; Narita S; Ahsan CR; Lu CL
    Microbiol Immunol; 1989; 33(11):951-5. PubMed ID: 2687649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane associated antigens in chemically-induced tumours.
    Baldwin RW
    Ser Haematol; 1972; 5(4):67-92. PubMed ID: 4133764
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
    Boyle MD; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vertical transmission of tumour resistance in guinea pigs.
    Wainberg MA; Minden P; Weiss DW
    Nature; 1976 Jan; 259(5540):213-5. PubMed ID: 175279
    [No Abstract]   [Full Text] [Related]  

  • 11. Embryonic antigens in tumor immunity.
    Della Porta G
    Johns Hopkins Med J Suppl; 1974; 3():279-87. PubMed ID: 4138923
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunochemical detection of tumor-specific and embryonic antigens of diethylnitrosamine-induced guinea pig tumors.
    Borsos T; Richardson AK; Ohanian SH; Leonard EJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1955-60. PubMed ID: 4128823
    [No Abstract]   [Full Text] [Related]  

  • 13. A 64 kDa protein from Mycobacterium bovis BCG shares the same antigenic determinants with line 10 hepatoma cells and has anti-line 10 tumor activity.
    Ahsan CR; Sasaki J
    FEBS Lett; 1991 Aug; 288(1-2):77-80. PubMed ID: 1715293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 16. The augmentation of concomitant tumor immunity with RNA.
    Wang BS; Deckers PJ
    J Surg Res; 1976 Mar; 20(3):183-94. PubMed ID: 1263482
    [No Abstract]   [Full Text] [Related]  

  • 17. Humoral immune responses to tumor-specific antigens in strain-2 guinea pigs.
    Smith HG; Leonard EJ
    J Natl Cancer Inst; 1974 Jul; 53(1):187-94. PubMed ID: 4366195
    [No Abstract]   [Full Text] [Related]  

  • 18. [Distribution of BCG antigens in mouse-tumor cells].
    Sasaki J; Sawamura D; Kamiya S; Yamatani S; Satoh K; Fukushi K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1074-6. PubMed ID: 3516075
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy.
    Bartlett GL; Zbar B
    J Natl Cancer Inst; 1972 Jun; 48(6):1709-26. PubMed ID: 4341405
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 248.